Back to mobile site

Piper Sandler Reiterates Overweight Rating on Edgewise Therapeutics (EWTX)

August 12, 2024 7:43 AM EDT Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $48.00 price target on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login